
    
      Patients with confirmed absence of cirrhosis will receive 8 weeks of treatment with
      Sofosbuvir and Simeprevir. Patients with confirmed presence of cirrhosis will receive 12
      weeks of treatment with Sofosbuvir and Simeprevir. All patients will followed for 24 weeks
      post-treatment. Presence or absence of cirrhosis will be evaluated by FibroScan if no
      historical liver biopsy or FibroScan is available.
    
  